- IN₹181.36bn
- IN₹202.94bn
- IN₹31.29bn
India pharma sector growth slows in November on lower volumes
Brief: Biocon Says Unit Biocon Biologics Divested Businesses To Eris Lifesciences On A Slump Sale Basis
Brief: Eris Lifesciences Sept-Quarter Consol Net Profit Rises
Brief: Eris Lifesciences Entered Into Term Loan Agreement To Avail Rupee Term Loan Facility Amounting To 1.21 Billion Rupees
Brief: India's Eris Lifesciences June-Quarter Consol Net Profit Rises
India's Eris Lifesciences up after HDFC Mutual Fund buys shares
India's Eris Lifesciences rises on bulk deal
Brief: Eris Lifesciences Propose To Demerge Domestic Formulations Business Of Oaknet And Amalgamate It With Co
Brief: India's Eris Lifesciences March-Quarter Consol Net Profit Falls
India's Eris Lifesciences rises most in over a year on block deals
India's Glenmark Pharma weighs selling stake in Glenmark Life - Mint
Brief: Eris Lifesciences Says Completion Of Acquisition Advanced To March 24, 2023
India's Eris rises on buying 9 dermatology brands
India's Dr Reddy's Laboratories up on deal to divest non-core brands
Deals of the day-Mergers and acquisitions
India's Eris buys nine dermatology brands from Dr. Reddy's for $33 mln (updated)
India's Eris Lifesciences buys nine dermatology brands from Dr.Reddy's
Brief: Eris Lifesciences Acquires Nine Dermatology Brands From Dr. Reddy's Laboratories
India's Eris Lifesciences to buy some dermatology brands from Glenmark Pharma